A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Takeda
Takeda
M.D. Anderson Cancer Center
University of Rochester
Ohio State University Comprehensive Cancer Center
Northwestern University
M.D. Anderson Cancer Center
Emory University
University of Washington
OHSU Knight Cancer Institute
Barbara Ann Karmanos Cancer Institute
University of Rochester